To examine whether the increase in full-length APP protein induced by high glucose treatment was via upregulation of APP gene transcription, we measured APP promoter activityin human neuroblastoma SH-SY5Y cells treated with 10 or 25 mM glucose. The gene discussed is APP; the disease is neuroblastoma.